Hungarian biochemist Katalin Karikó developed a way to modify messenger ribonucleic acid for safe use in the human body, paving the way for its use in COVID‑19 and other vaccines, as well as prospective therapies for cancer and heart disease.
European Patent Office announces the finalists for the European Inventor Award 2022 Award highlights breakthroughs in cancer research, renewable energy, climate innovation, green industry, medical technology and manufacturing
One therapeutic vaccine platform to treat several forms of cancer: Madiha Derouazi and Elodie Belnoue named as joint finalists for European Inventor Award 2022
